These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27941020)

  • 21. Fusion-optimized intervals (FOI): a new method to achieve the narrowest QRS for optimization of the AV and VV intervals in patients undergoing cardiac resynchronization therapy.
    Arbelo E; Tolosana JM; Trucco E; Penela D; Borràs R; Doltra A; Andreu D; Aceña M; Berruezo A; Sitges M; Mansour F; Castel A; Matas M; Brugada J; Mont L
    J Cardiovasc Electrophysiol; 2014 Mar; 25(3):283-92. PubMed ID: 24237881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac-resynchronization therapy in patients with systolic heart failure and QRS interval ≤130 ms: insights from a meta-analysis.
    Shah RM; Patel D; Molnar J; Ellenbogen KA; Koneru JN
    Europace; 2015 Feb; 17(2):267-73. PubMed ID: 25164431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac contractility modulation treatment in patients with symptomatic heart failure despite optimal medical therapy and cardiac resynchronization therapy (CRT).
    Kuschyk J; Nägele H; Heinz-Kuck K; Butter C; Lawo T; Wietholt D; Roeger S; Gutterman D; Burkhoff D; Rousso B; Borggrefe M
    Int J Cardiol; 2019 Feb; 277():173-177. PubMed ID: 30409733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocardial acceleration (sonR) vs. ultrasound-derived time intervals in recipients of cardiac resynchronization therapy systems.
    Donal E; Giorgis L; Cazeau S; Leclercq C; Senhadji L; Amblard A; Jauvert G; Burban M; Hernández A; Mabo P
    Europace; 2011 Mar; 13(3):402-8. PubMed ID: 21212110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrically vs. imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial.
    Stephansen C; Sommer A; Kronborg MB; Jensen JM; Nørgaard BL; Gerdes C; Kristensen J; Jensen HK; Fyenbo DB; Bouchelouche K; Nielsen JC
    Europace; 2019 Sep; 21(9):1369-1377. PubMed ID: 31274152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(13):1-60. PubMed ID: 23074464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Empiric versus imaging guided left ventricular lead placement in cardiac resynchronization therapy (ImagingCRT): study protocol for a randomized controlled trial.
    Sommer A; Kronborg MB; Poulsen SH; Böttcher M; Nørgaard BL; Bouchelouche K; Mortensen PT; Gerdes C; Nielsen JC
    Trials; 2013 Apr; 14():113. PubMed ID: 23782792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-Term Extrapolation of Clinical Benefits Among Patients With Mild Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the 5-Year Follow-Up From the REVERSE Study.
    Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT
    JACC Heart Fail; 2015 Sep; 3(9):691-700. PubMed ID: 26277764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using Machine-Learning for Prediction of the Response to Cardiac Resynchronization Therapy: The SMART-AV Study.
    Howell SJ; Stivland T; Stein K; Ellenbogen KA; Tereshchenko LG
    JACC Clin Electrophysiol; 2021 Dec; 7(12):1505-1515. PubMed ID: 34454883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implant-based multi-parameter telemonitoring of patients with heart failure and a defibrillator with vs. without cardiac resynchronization therapy option: a subanalysis of the IN-TIME trial.
    Geller JC; Lewalter T; Bruun NE; Taborsky M; Bode F; Nielsen JC; Stellbrink C; Schön S; Mühling H; Oswald H; Reif S; Kääb S; Illes P; Proff J; Dagres N; Hindricks G;
    Clin Res Cardiol; 2019 Oct; 108(10):1117-1127. PubMed ID: 30874886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale and design of the BUDAPEST-CRT Upgrade Study: a prospective, randomized, multicentre clinical trial.
    Merkely B; Kosztin A; Roka A; Geller L; Zima E; Kovacs A; Boros AM; Klein H; Wranicz JK; Hindricks G; Clemens M; Duray GZ; Moss AJ; Goldenberg I; Kutyifa V
    Europace; 2017 Sep; 19(9):1549-1555. PubMed ID: 28339581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of VV optimization in relation to left ventricular lead position: an acute haemodynamic study.
    Khan FZ; Virdee MS; Read PA; Pugh PJ; Begley D; Fynn SP; Dutka DP
    Europace; 2011 Jun; 13(6):845-52. PubMed ID: 21427090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute beneficial hemodynamic effects of a novel 3D-echocardiographic optimization protocol in cardiac resynchronization therapy.
    Sonne C; Bott-Flügel L; Hauck S; Lesevic H; Barthel P; Michalk F; Hoppe K; Hausleiter J; Schömig A; Kolb C
    PLoS One; 2012; 7(2):e30964. PubMed ID: 22319598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
    Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
    J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of right ventriclular systolic function prior to cardiac resynchronization therapy: Does it make any difference?
    Abdelhamid MA; Ghanem MT; Abdelmotaleb AM
    Indian Heart J; 2017; 69(6):731-735. PubMed ID: 29174250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.
    Khan FZ; Virdee MS; Palmer CR; Pugh PJ; O'Halloran D; Elsik M; Read PA; Begley D; Fynn SP; Dutka DP
    J Am Coll Cardiol; 2012 Apr; 59(17):1509-18. PubMed ID: 22405632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
    Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
    Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of QRS Narrowing After Cardiac Resynchronization Therapy on Functional Mitral Regurgitation in Patients With Systolic Heart Failure.
    Karaca O; Omaygenc MO; Cakal B; Cakal SD; Gunes HM; Barutcu I; Boztosun B; Kilicaslan F
    Am J Cardiol; 2016 Feb; 117(3):412-9. PubMed ID: 26721652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of a Novel Adaptive Optimization Algorithm on 30-Day Readmissions: Evidence From the Adaptive CRT Trial.
    Starling RC; Krum H; Bril S; Tsintzos SI; Rogers T; Hudnall JH; Martin DO
    JACC Heart Fail; 2015 Jul; 3(7):565-572. PubMed ID: 26071616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of cardiac resynchronization therapy on left atrial reverse remodeling: role of echocardiographic AV delay optimization.
    Malagoli A; Rossi L; Franchi F; Piepoli MF; Malavasi V; Casali E; Modena MG; Villani GQ
    Int J Cardiol; 2013 Aug; 167(4):1456-60. PubMed ID: 22560916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.